Gut bacteria and intestinal scarring study
Part of Digestive system clinical trials.
This study looks at how bacteria in the gut may affect scarring (fibrosis) in the intestines, especially in people with Crohn's disease. By joining, you may help researchers understand why scarring happens, which could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 69 years old
- You must be willing to sign a consent form
- If you have Crohn's disease, your doctor must have already classified your disease as type B1, B2, or B3
- If you don't have Crohn's, you must be having surgery for a non-Crohn's condition like diverticulitis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with Crohn's disease or ulcerative colitis to see how their intestine heals after surgery. It looks for signs that can predict whether inflammation will return or complications will happen.
This study looks at proteins from your body and gut bacteria to understand Crohn's disease better. You may join if you are about to have your first colonoscopy for suspected Crohn's and have not had any treatment yet.
This study analyzes your gut bacteria to see if it can predict how well you will respond to Crohn's disease treatments. If you are having a colonoscopy for routine care, you may be eligible.
This study looks at people with Crohn's disease that is hard to treat. It aims to understand the disease better and see how well current treatments work.
This study uses a computer program to look at scar tissue in biopsy samples from people with Crohn's disease. The goal is to see if the amount of scar tissue is linked to patient history and how the disease progresses over time.
This study follows children newly diagnosed with Crohn’s disease to see how results from scans and endoscopy (camera scope) relate to outcomes over the first year. It may help doctors choose better early treatment plans and monitor children more effectively.
Hear when a new Crohn Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.